FindTrial
Sign In

Study to Evaluate OMR-12200 as a Negative Contrast Agent for Magnetic Resonance Cholangio-Pancreatography

Study to Evaluate OMR-12200 as a Negative Contrast Agent for Magnetic Resonance Cholangio-Pancreatography

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220300
Enrollment
Unknown
Registered
2006-10-02
Start date
2006-10-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients scheduled to undergo MRCP

Interventions

investigational material(s) Generic name etc : OMR-12200 INN of investigational material : Therapeutic category code : 729 Other diagnostic agents (except extracorporeal diagnostic medicines) Dosage

Sponsors

Otsuka Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients age 20 years or older and less than 80 years (at time of informed consent)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficacy, Safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026